Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice
Authors
Keywords
Cysteinyl leukotriene receptor 1, Depression, Chronic mild stress, Neuroinflammation
Journal
PSYCHOPHARMACOLOGY
Volume 233, Issue 9, Pages 1739-1749
Publisher
Springer Nature
Online
2015-11-07
DOI
10.1007/s00213-015-4136-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation
- (2015) B. Liu et al. NEUROSCIENCE
- Antidepressant-Like Effects of Cordycepin in a Mice Model of Chronic Unpredictable Mild Stress
- (2014) Zhang Tianzhu et al. Evidence-based Complementary and Alternative Medicine
- Cyclin-Dependent Kinase 5 in the Ventral Tegmental Area Regulates Depression-Related Behaviors
- (2014) P. Zhong et al. JOURNAL OF NEUROSCIENCE
- Protective effect of pranlukast on Aβ 1–42-induced cognitive deficits associated with downregulation of cysteinyl leukotriene receptor 1
- (2013) Su-Su Tang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Leukotriene D4 induces amyloid-β generation via CysLT1R-mediated NF-κB pathways in primary neurons
- (2013) Xiao Yun Wang et al. NEUROCHEMISTRY INTERNATIONAL
- Differential Control of Learning and Anxiety along the Dorsoventral Axis of the Dentate Gyrus
- (2013) Mazen A. Kheirbek et al. NEURON
- Antiasthmatic Drugs Targeting the Cysteinyl Leukotriene Receptor 1 Alleviate Central Nervous System Inflammatory Cell Infiltration and Pathogenesis of Experimental Autoimmune Encephalomyelitis
- (2011) L. Wang et al. JOURNAL OF IMMUNOLOGY
- Open questions in current models of antidepressant action
- (2010) A Tanti et al. BRITISH JOURNAL OF PHARMACOLOGY
- Therapeutic Options for Treatment-Resistant Depression
- (2010) Richard C. Shelton et al. CNS DRUGS
- Cysteinyl Leukotrienes and Their Receptors: Molecular and Functional Characteristics
- (2010) R.K. Singh et al. PHARMACOLOGY
- Cysteinyl Leukotrienes Induce Monocyte Chemoattractant Protein-1 in Human Monocyte/Macrophages via Mitogen-Activated Protein Kinase and Nuclear Factor-κB Pathways
- (2009) Kunio Hashimoto et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Leukotriene D4 Stimulates the Migration but Not Proliferation of Endothelial Cells Mediated by the Cysteinyl Leukotriene CysLT1 Receptor via the Extracellular Signal-Regulated Kinase Pathway
- (2009) Yu-Mei Yuan et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis
- (2009) D Taliaz et al. MOLECULAR PSYCHIATRY
- Nuclear Factor-κB Activation: From Bench to Bedside
- (2008) Gautam Sethi et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Major Depressive Disorder
- (2008) R.H. Belmaker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leukotriene D4 Upregulates MUC2 Gene Transcription in Human Epithelial Cells
- (2008) Shinya Suzuki et al. PHARMACOLOGY
- From inflammation to sickness and depression: when the immune system subjugates the brain
- (2007) Robert Dantzer et al. NATURE REVIEWS NEUROSCIENCE
- The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma—A comparison with leukotriene D4 induced broncoconstriction
- (2007) V. Schelfhout et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started